6-methyl-2-propylimino-6, 7-dihydro-5 H-benzo [1, 3]-oxathiol- 4-one (LYR71), a derivative of trimeric resveratrol, was also effective against breast cancer growth via inhibiting the STAT3-mediated MMP-9 expression [94]. Here, MMP9 is linked to breast cancer.